CoChat

Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension

Jansen, Pieter M., Frenkel, Wijnanda J., van den Born, Bert-Jan H., de Bruijne, Emile L.E., Deinum, Jaap, Kerstens, Michiel N., Arnoldus, Joyce H.A., Woittiez, Arend Jan, Wijbenga, Johanna A.M., Zietse, Robert, Danser, A.H. Jan, van den Meiracker, Anton H. · 2013 · Journal of Hypertension
Cited by 26

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

BACKGROUND: Add-on therapy with aldosterone receptor antagonists has been reported to lower blood pressure (BP) in patients with uncontrolled hypertension. We assessed potential predictors of this response. METHODS: In essential hypertensive patients with uncontrolled BP, despite the use of at least two antihypertensives, plasma renin and aldosterone concentrations and the transtubular potassium gradient (TTKG) were measured. Patients were treated with eplerenone 50 mg daily on top of their own medication. The office and ambulatory BP response and biochemical changes were evaluated after 1 week and 3 months of treatment and 6 weeks after discontinuation. Potential predictors for the change in 24-h ambulatory BP were tested in a multivariate regression model. RESULTS: One hundred and seventeen patients with a mean age of 50.5 ± 6.6 years were included. Office BP decreased from 149/91 to 142/87 mmHg (P < 0.001) and ambulatory BP from 141/87 to 132/83 mmHg after 3 months of treatment (P < 0.001). Six weeks after discontinuation of eplerenone, office and ambulatory BP measurements returned to baseline values. Treatment resulted in a small rise in serum potassium and creatinine, and a small decrease in the TTKG. In a multivariate model, neither renin, aldosterone, or their ratio, nor the TTKG predicted the BP response. Only baseline ambulatory SBP predicted the BP response, whereas the presence of left ventricular hypertrophy was associated with a smaller BP reduction. CONCLUSION: Add-on therapy with eplerenone effectively lowers BP in patients with difficult-to-treat primary hypertension. This effect is unrelated to circulating renin-angiotensin-aldosterone system activity and renal mineralocorticoid receptor activity as assessed by the TTKG.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1097/hjh.0b013e32835b71d6

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 5 references

Cited by

See all 26

Metadata

Authors
Jansen, P. M., Frenkel, W. J., van den Born, B.-J. H., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Arnoldus, J. H. A., Woittiez, A. J., Wijbenga, J. A. M., Zietse, R., Danser, A. H. J., & van den Meiracker, A. H.
Venue
Journal of Hypertension
Published
2013-02
Volume
31
Issue
2
Pages
404-413
ISSN
0263-6352 (ISSN-L)
OpenAlex
W2151653301
Cited by
26
References
5
FWCI
2.99
Type
journal article
Language
en
Open access
closed

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension. https://app.cochat.ai/papers/10.1097/hjh.0b013e32835b71d6
The paper
Jansen, P. M., Frenkel, W. J., van den Born, B.-J. H., de Bruijne, E. L. E., Deinum, J., Kerstens, M. N., Arnoldus, J. H. A., Woittiez, A. J., Wijbenga, J. A. M., Zietse, R., Danser, A. H. J., & van den Meiracker, A. H. (2013). Determinants of blood pressure reduction by eplerenone in uncontrolled hypertension. Journal of Hypertension. https://doi.org/10.1097/hjh.0b013e32835b71d6

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.